BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16804700)

  • 21. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.
    Hudson M; Taillefer S; Steele R; Dunne J; Johnson SR; Jones N; Mathieu JP; Baron M
    Clin Exp Rheumatol; 2007; 25(5):754-7. PubMed ID: 18078627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very early diagnosis of systemic sclerosis.
    Bellando-Randone S; Guiducci S; Matucci-Cerinic M
    Pol Arch Med Wewn; 2012; 122 Suppl 1():18-23. PubMed ID: 23222375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of scleroderma and pseudoscleroderma.
    Fabri M; Hunzelmann N
    J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.
    Smith V; Herrick AL; Ingegnoli F; Damjanov N; De Angelis R; Denton CP; Distler O; Espejo K; Foeldvari I; Frech T; Garro B; Gutierrez M; Gyger G; Hachulla E; Hesselstrand R; Iagnocco A; Kayser C; Melsens K; Müller-Ladner U; Paolino S; Pizzorni C; Radic M; Riccieri V; Snow M; Stevens W; Sulli A; van Laar JM; Vonk MC; Vanhaecke A; Cutolo M;
    Autoimmun Rev; 2020 Mar; 19(3):102458. PubMed ID: 31927087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Capillaroscopy in the diagnosis of systemic sclerosis].
    Jafiszow U; Kowal-Bielecka O; Sierakowski S
    Postepy Hig Med Dosw (Online); 2005; 59():340-5. PubMed ID: 16012395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
    Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
    Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.
    Zheng B; Vincent C; Fritzler MJ; Senécal JL; Koenig M; Joyal F
    J Rheumatol; 2017 Jan; 44(1):33-39. PubMed ID: 27744398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
    Ingegnoli F; Boracchi P; Gualtierotti R; Biganzoli EM; Zeni S; Lubatti C; Fantini F
    Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
    Bellis R; Francès C; Barète S; Senet P
    Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation Working Group of the French Vascular Medicine Society].
    Pistorius MA; Carpentier PH;
    J Mal Vasc; 2012 Jul; 37(4):207-12. PubMed ID: 22749761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic SR; Damjanov NS; Vujasinovic Stupar NZ; Baltic S; Babic DD
    Rheumatol Int; 2013 Dec; 33(12):2967-73. PubMed ID: 23934522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capillaroscopy.
    Cutolo M; Pizzorni C; Secchi ME; Sulli A
    Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of potential classification criteria for systemic sclerosis.
    Johnson SR; Fransen J; Khanna D; Baron M; van den Hoogen F; Medsger TA; Peschken CA; Carreira PE; Riemekasten G; Tyndall A; Matucci-Cerinic M; Pope JE
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):358-67. PubMed ID: 22052658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and classification of systemic sclerosis.
    Hachulla E; Launay D
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):78-83. PubMed ID: 20143182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nailfold capillaroscopy in juvenile rheumatic diseases: known measures, patterns and indications.
    Gerhold K; Becker MO
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-183-8. PubMed ID: 24960119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation working group of the Société française de médecine vasculaire].
    Pistorius MA; Carpentier PH;
    Ann Dermatol Venereol; 2013; 140(8-9):549-54. PubMed ID: 24034643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach.
    Bellando-Randone S; Matucci-Cerinic M
    Curr Rheumatol Rev; 2013; 9(4):245-8. PubMed ID: 26932288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
    Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
    J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting.
    Kuwana M
    J Nippon Med Sch; 2017; 84(2):56-63. PubMed ID: 28502960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.